Brevan Howard Capital Management’s Pediatrix Medical MD Stock Holding History

Brevan Howard Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Buy	13,070 +3,487	+36%	+$79.3K	﹤0.01%	1653
2026 Q1	$205K	Sell	9,583 -17,576	-65%	-$366K	﹤0.01%	1883
2025 Q4	$581K	Sell	27,159 -2,833	-9%	-$58.1K	0.01%	1026
2025 Q3	$502K	Sell	29,992 -55,304	-65%	-$829K	﹤0.01%	1293
2025 Q2	$1.22M	Buy	+85,296	New	+$1.17M	0.01%	968
2024 Q4	–	Sell	-27,620	Closed	-$320K	–	1280
2024 Q3	$320K	Sell	27,620 -9,277	-25%	-$87.5K	﹤0.01%	828
2024 Q2	$279K	Buy	+36,897	New	+$305K	﹤0.01%	802
2024 Q1	–	Sell	-14,364	Closed	-$134K	–	1211
2023 Q4	$134K	Buy	+14,364	New	+$149K	﹤0.01%	927

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Brevan Howard Capital Management's MD Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Pediatrix Medical (MD) stake by 36% in Q2 2026, buying an estimated $79.3K and bringing the position to 13,070 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Brevan Howard Capital Management first reported a position in MD in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.22M in Q2 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Brevan Howard Capital Management held 13,070 shares of Pediatrix Medical worth $331K as of Q2 2026.
Brevan Howard Capital Management bought 3,487 Pediatrix Medical shares in Q2 2026, an estimated $79.3K.
Pediatrix Medical made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1653 holding.
Brevan Howard Capital Management first reported a position in Pediatrix Medical in Q4 2023 and has held it in 8 quarters since.
Brevan Howard Capital Management's Pediatrix Medical position peaked at $1.22M in Q2 2025.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.